Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.

Our study found key dysregulated genes involved in CRC and potential drugs to combat it, which may provide novel insights and potential biomarkers for prognosis, as well as providing new CRC treatments.